TOP2A,

Xiaodong Shi1, Baiyang Song2, Boqian Wang3

  • 1Department of Urology, Zhejiang Engineering Research Center of Innovative Technologies and Diagnostic Devices for Urological Diseases, Ningbo Clinical Research Center for Urological Disease, Medical and Engineering Integration Laboratory, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China.

Translational oncology
|December 14, 2025
PubMed
概括

在癌中,托皮索马酶IIα (TOP2A) 过度表达,导致瘤进展. 一个新的基于TOP2A的模型预测了脏清细胞癌 (KIRC) 的预后并确定了治疗点.